...
首页> 外文期刊>Melanoma research >Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivo.
【24h】

Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivo.

机译:人黑素瘤中突变ras的过表达增加了体外侵袭性,增殖和锚定非依赖性生长,并在体内诱导肿瘤形成和恶病质。

获取原文
获取原文并翻译 | 示例

摘要

Malignant melanoma is the deadliest form of skin cancer. Previous studies have shown that the incidence of ras mutation increases with progression of melanoma, but that such mutations may not be present in the earliest radial growth phase melanomas. Recently it has been proposed that introduction of ras mutations into cells deficient in tumour suppressor genes such as p16 (INK4a) is sufficient to induce characteristics of cellular transformation such as anchorage-independent growth and tumour formation in vivo. To test this hypothesis in human melanoma, mutant N-ras, mutant H-ras or wild-type H-ras genes were transfected by electroporation into WM35 cells, a p16-deficient human melanoma cell line of low invasive potential. Increased expression of mutant ras p21 enhanced anchorage-dependent cell growth on tissue culture plastic. In addition, overexpression of mutant N-ras and H-ras, but not of wild-type H-ras, increased the experimental invasive potential, inducing anchorage-independent growth in soft agar, increasing cell motility measured by time-lapse video microscopy, and increasing invasiveness through reconstituted basement membranes. Finally, overexpression of mutant H-ras in melanoma cells was shown to increase tumorigenicity and to induce cachexia when H-ras transfected cell lines were injected subcutaneously in severe combined immunodeficiency (SCID) mice. Thus the addition of activating ras mutations to a melanoma cell line already deficient in p16 leads to enhanced proliferation, survival and migration in vitro and to enhanced subcutaneous tumour formation in vivo. This phenotype is typical of the behaviour of vertical growth phase (VGP) melanoma, and we propose that activation of the ras signalling pathway in the presence of deletions in p16 or related tumour suppressors can induce the VGP melanoma phenotype.
机译:恶性黑色素瘤是皮肤癌最致命的形式。先前的研究表明,ras突变的发生率随着黑色素瘤的进展而增加,但是这种突变可能并不存在于最早的放射状生长期的黑色素瘤中。最近,已经提出将ras突变引入缺乏肿瘤抑制基因例如p16(INK4a)的细胞中足以诱导细胞转化的特征,例如在体内不依赖锚定的生长和肿瘤形成。为了在人黑素瘤中测试该假设,通过电穿孔将突变的N-ras,突变的H-ras或野生型H-ras基因转染到WM35细胞中,WM35细胞是p16缺陷的低侵染潜力的人黑素瘤细胞系。突变ras p21表达的增加增强了组织培养塑料上锚定依赖性细胞的生长。此外,突变型N-ras和H-ras的过表达(而不是野生型H-ras的过表达)增加了实验性侵袭潜力,诱导了软琼脂中锚定非依赖性生长,并通过延时视频显微镜观察到了细胞活力的增加,并通过重建的基底膜增加侵袭性。最后,当在严重的联合免疫缺陷(SCID)小鼠中皮下注射H-ras转染的细胞系时,黑色素瘤细胞中突变H-ras的过表达可增加致瘤性并诱导恶病质。因此,向已经缺乏p16的黑素瘤细胞系中添加激活ras突变会导致体外增殖,存活和迁移增强,以及体内皮下肿瘤形成增强。此表型是垂直生长阶段(VGP)黑色素瘤行为的典型表现,我们提出在p16缺失或相关肿瘤抑制因子缺失的情况下激活ras信号通路可以诱导VGP黑色素瘤表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号